Related Experiment Video
Updated: Jul 5, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
Published on: June 25, 2018
Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children
Thierry Ntimbane1, Preetha Krishnamoorthy, Céline Huot
1Department of Nutrition, University of Montreal, Montreal, Canada.
Insights
Cystic fibrosis (CF) children exhibit increased oxidative stress linked to impaired glucose metabolism. Nutritional recommendations (NR) may help delay cystic fibrosis-related diabetes (CFRD) onset in these patients.
Area of Science:
- Pediatrics
- Endocrinology
- Metabolic Disorders
Background:
- Cystic fibrosis (CF) is associated with chronic inflammation and heightened oxidative stress.
- Understanding the interplay between glucose metabolism and oxidative stress in CF is crucial for patient management.
Purpose of the Study:
- To investigate the relationship between glucose tolerance and markers of oxidative stress in children with cystic fibrosis.
- To assess the impact of nutritional interventions on glucose metabolism and oxidative stress in CF patients.
Main Methods:
- Oral glucose tolerance testing was performed on 31 children (10-18 years old).
- Blood and urine samples were analyzed for oxidative stress markers (glutathione, HNE-P, DHN-MA).
- Plasma fatty acid profiles were assessed, and patients with impaired glucose tolerance (IGT) were followed after nutritional recommendations (NR).
Main Results:
- 42% of CF children presented with impaired glucose tolerance (IGT), and 6% had cystic fibrosis-related diabetes (CFRD).
- Elevated oxidative stress marker HNE-P correlated with poorer glucose tolerance.
- Nutritional recommendations (NR) led to normalization of glucose tolerance in 67% of IGT patients, while 22% progressed to CFRD.
Conclusions:
- CF children demonstrate increased oxidative stress that correlates with worsening glucose metabolism.
- Nutritional interventions show promise in delaying the progression to CFRD in pediatric CF patients.
Background:
Cystic fibrosis (CF) is characterized by chronic inflammation with increased oxidative stress. We evaluated the relationship between glucose tolerance and oxidative stress in CF children.
Methods:
Patients 10-18 years old underwent oral glucose tolerance testing (n=31). At 2-h, we assessed blood glutathione and 4-hydroxynonenal-protein adducts (HNE-P), and urine 1,4-dihydroxynonane-mercapturic acid conjugate (DHN-MA). Plasma fatty acid (FA) profile was performed. Patients with impaired glucose tolerance (IGT) were retested 6 to 24 months later and received additional nutritional recommendations (NR) when possible.
Results:
Fifty-two percent of patients had normal glucose tolerance (NGT), 42% IGT and 6% cystic fibrosis-related diabetes (CFRD). HNE-P concentrations significantly increased with diabetes (109%). Two-h BG correlated positively with HNE-P and negatively with DHN-MA. FA profile was modified with IGT. Of retested IGT patients, 25% received no NR; they remained IGT at 6 months and progressed to CFRD. Of those who received NR, 67% normalized, 11% remained intolerant and 22% developed CFRD. HNE-P levels dropped (88%) in IGT patients reverting to NGT, increased (94%) in the IGT patients with NR developing CFRD, decreased (90%) with persistent IGT.
Conclusion:
CF children showed evidence of increased oxidative stress with worsening of glucose metabolism. NR may delay the appearance of CFRD.
More Related Videos
07:38Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
09:31Analyzing Oxidative Stress in Murine Intestinal Organoids using Reactive Oxygen Species-Sensitive Fluorogenic Probe
Published on: September 17, 2021
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Type II Diabetes I: Introduction
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Psychoneuroimmunology: Diabetes and Cancer
Type II Diabetes II: Pathophysiology